Funeng Jiang
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
Papers in
-
- Ubiquitin and proteasome pathways 5
- Circular RNAs in diseases 5
-
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 4
- Cancer, Hypoxia, and Metabolism 4
- Co-authors
- Weide Zhong (49 shared papers)Huichan He (24 shared papers)Zhaodong Han (21 shared papers)Yuxiang Liang (18 shared papers)Qi-Shan Dai (10 shared papers)Jianguo Zhu (14 shared papers)Yongding Wu (12 shared papers)Yanqiong Zhang (7 shared papers)
- Journals
- OncoTargets and Therapy (3 papers)Pathology & Oncology Research (3 papers)BioMed Research International (2 papers)Current Cancer Drug Targets (2 papers)Current Molecular Medicine (2 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Funeng Jiang
62 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 97
- Cancer Research 455
- Molecular Biology 796
- Oncology 222
- Pulmonary and Respiratory Medicine 255
- Cell Biology 104
Countries citing papers authored by Funeng Jiang
This map shows the geographic impact of Funeng Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Funeng Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Funeng Jiang more than expected).
Fields of papers citing papers by Funeng Jiang
This network shows the impact of papers produced by Funeng Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Funeng Jiang. The network helps show where Funeng Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Funeng Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 103 | |
| 2 | 2013 | 89 | |
| 3 | 2014 | 63 | |
| 4 | 2023 | 55 | |
| 5 | 2016 | 51 | |
| 6 | 2020 | 51 | |
| 7 | 2016 | 47 | |
| 8 | 2014 | 47 | |
| 9 | 2018 | 46 | |
| 10 | 2014 | 44 | |
| 11 | 2013 | 43 | |
| 12 | 2011 | 42 | |
| 13 | 2018 | 41 | |
| 14 | 2014 | 41 | |
| 15 | 2013 | 41 | |
| 16 | Down-regulation of dual-specificity phosphatase 5 predicts poor prognosis of patients with prostate cancer. | 2015 | 39 |
| 17 | 2013 | 36 | |
| 18 | 2018 | 35 | |
| 19 | 2014 | 33 | |
| 20 | 2018 | 31 |
About Funeng Jiang
Funeng Jiang is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 65 papers that have together received 1.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (6 papers), MicroRNA in disease regulation (6 papers), Ubiquitin and proteasome pathways (5 papers), Circular RNAs in diseases (5 papers), Autophagy in Disease and Therapy (4 papers), Cancer-related molecular mechanisms research (4 papers), Cancer-related Molecular Pathways (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (455 citations), Molecular Biology (796 citations), Oncology (222 citations), Pulmonary and Respiratory Medicine (255 citations) and Cell Biology (104 citations). Funeng Jiang has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Weide Zhong, Huichan He, Zhaodong Han, Yuxiang Liang, Qi-Shan Dai, Jianguo Zhu, Yongding Wu, Yanqiong Zhang, Chin‐Lee Wu and Zhuoyuan Lin. Their work appears in journals such as OncoTargets and Therapy, Pathology & Oncology Research, BioMed Research International, Current Cancer Drug Targets and Current Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.